FDA Adverse Event Injury Summary report: N

LOGIC TIBIA IMPLANT PSC INSERT, SZ 3, 15MM

MDR report key: 24114344 · Received January 20, 2026

Report

Report Number
1038671-2026-00057
Event Type
Injury
Date Received
January 20, 2026
Report Date
January 20, 2026
Manufacturer
EXACTECH, INC.
Product Code
JWH
UDI-DI
10885862173584
PMA / PMN Number
K110547
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

D10: 02-012-60-1612 - TRU STEM EXT 16MM X 120MM: (B)(6). 208-05-03 - CC DISTAL FEM AUGMENT SZ 3, 5MM: (B)(6). 208-05-03 - CC DISTAL FEM AUGMENT SZ 3, 5MM: (B)(6). 02-010-06-0230 - TRU CC FEMORAL SIZE 3 LEFT: (B)(6). 02-010-06-0531 - TRU POST. AUG. SIZE 3, 5MM: (B)(6). 02-010-06-0531 - TRU POST. AUG. SIZE 3, 5MM: (B)(6). THE REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. NO DEVICE WAS RETURNED FOR EVALUATION; FURTHER, PHOTOGRAPHS AND/OR RADIOGRAPH IMAGES WERE NOT PROVIDED FOR REVIEW. OPERATIVE NOTES AND/OR MEDICAL RECORDS WERE NOT PROVIDED FOR REVIEW OF USAGE/TECHNIQUE. A DEFINITIVE ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED. IF ANY FURTHER INFORMATION IS OBTAINED THAT WOULD CHANGE OR ALTER ANY INFORMATION PROVIDED, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY.

Description of Event or Problem · 0

IT WAS REPORTED THE PATIENT UNDERWENT A LEFT KNEE REVISION APPROXIMATELY SEVEN AND A HALF (7.5) YEARS AGO AND ALLEGES THAT THEY WILL NEED ANOTHER REVISION PROCEDURE DUE TO PROSTHESIS WEAR. IT IS UNKNOWN IF A REVISION HAS BEEN PLANNED. NO SURGICAL OR MEDICAL INTERVENTIONS WERE REPORTED. NO PATIENT IMPACT WAS REPORTED. NO OTHER INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
181489 LOGIC TIBIA IMPLANT PSC INSERT, SZ 3, 15MM PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL JWH EXACTECH, INC. 10885862173584

Patients

Seq Age Sex Outcome Treatment
1 NA Female Other SEE H11.